That's TIS and the study refers to the various (uncontrolled) UK clinical tests in 2010/2011 with limited patient numbers.
This stuff is regurgitated over and over but nobody cares to look at the actual underlying facts and/or deliberately obfuscates them.
I seriously doubt that this was presented to the FDA for the current Phase II study. One thing is sure: It was not good enough to pass the EMA.
See Post 30854809 - and for further details look at the TIS threads for 2009-2011.
But on a more upbeat note: I shall gather a few dollars more and fully participate in the CR - not because I am a believer but I might just get my investment back in a year or so.
- Forums
- ASX - By Stock
- Ann: Investor Presentation
That's TIS and the study refers to the various (uncontrolled) UK...
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non-Executive Director
Simon Kidston
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online